Every Ultomiris assistance program you may qualify for - manufacturer and foundation programs, not a discount card. About a minute, no login.
Every Ultomiris program linked to its official source, with the date we checked it - rules, income limits, and application links included.
Tell us five things. We’ll do the rest.
Ultomiris (ravulizumab-cwvz) is a long-acting terminal complement inhibitor (c5) made by Alexion (AstraZeneca Rare Disease). It is commonly prescribed for: Paroxysmal nocturnal hemoglobinuria (PNH), Atypical hemolytic uremic syndrome (aHUS), Generalized myasthenia gravis (gMG, AChR antibody-positive), Neuromyelitis optica spectrum disorder (NMOSD).
Ultomiris offers more than one kind of program, and they have opposite rules:
We show both programs, and the real income limits, below. Or read the full copay card vs patient assistance guide
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Alexion (AstraZeneca Rare Disease) · Ultomiris
Patient pays: covers out-of-pocket medication costs up to $15,000 per calendar year
commercial insurance
How to apply: online, phone, or email
Alexion (AstraZeneca Rare Disease) · Ultomiris
uninsured · underinsured
How to apply: online or phone
Your prescriber signs part of the form.
Keep tabs on Ultomiris assistance
We recheck every program’s rules on a regular schedule - income limits, eligibility, and whether a program is still open all change without much notice. Leave your email and we’ll send a short note if something changes for Ultomiris.
Yes. Alexion (AstraZeneca Rare Disease) runs the Alexion OneSource Patient Assistance Program - Ultomiris, which provides Ultomiris free of charge to eligible patients. The full rules and the official application link are in the program list above.
Medicare coverage for Ultomiris depends on your own plan: depending on how it is given, a drug can fall under Part B (administered in a clinic) or Part D (filled at a pharmacy), and each plan decides what it covers. Your plan's documents or Medicare's plan finder are the only reliable check. Separate from coverage, none of the Ultomiris assistance programs we track currently accept Medicare patients.
Yes - the Alexion OneSource CoPay Program - Ultomiris from Alexion (AstraZeneca Rare Disease). Eligible patients pay covers out-of-pocket medication costs up to $15,000 per calendar year. It works for patients with commercial (private) insurance. Patients on Medicare or Medicaid cannot use the card itself. If you searched for an Ultomiris coupon, this manufacturer card is the official version of it.
The official application form for the Alexion OneSource Patient Assistance Program - Ultomiris is on alexiononesource.com - the application links on this page go straight to the program's own form. Some programs call it an enrollment form; it is the same document. Applying is always free; never pay a third-party service to file a patient assistance form for you.
None of the Ultomiris programs we track currently accept Medicare or Medicaid. If that changes, we will update this page.
Manufacturers like Alexion (AstraZeneca Rare Disease) use "patient support program" as an umbrella term for nurse lines, insurance navigation, and financial help. The financial help is what we track here - for Ultomiris that is the Alexion OneSource Patient Assistance Program - Ultomiris. The support phone line is listed on the official program site linked above.